Abstract
This Letter describes the discovery and SAR of three novel series of mGluR5 non-competitive antagonists/negative allosteric modulators (NAMs) not based on manipulation of an MPEP/MTEP chemotype identified by a functional HTS approach. This work demonstrates fundamentally new mGluR5 NAM chemotypes with submicromolar potencies, and further examples of a mode of pharmacology 'switch' to provide PAMs with a non-MPEP scaffold.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Benzamides / chemical synthesis*
-
Benzamides / chemistry
-
Benzamides / pharmacology*
-
Benzimidazoles / chemical synthesis*
-
Benzimidazoles / chemistry
-
Benzimidazoles / pharmacology*
-
High-Throughput Screening Assays / methods*
-
Molecular Structure
-
Phthalimides / chemical synthesis*
-
Phthalimides / chemistry
-
Phthalimides / pharmacology*
-
Pyridines / chemistry
-
Pyridines / pharmacology
-
Receptor, Metabotropic Glutamate 5
-
Receptors, Metabotropic Glutamate / antagonists & inhibitors*
-
Structure-Activity Relationship
-
Thiazoles / chemistry
-
Thiazoles / pharmacology
Substances
-
3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine
-
3-(phthalimidyl)-N-(2-hydroxyphenyl)benzamide
-
Benzamides
-
Benzimidazoles
-
N-(3-(1H-benzo(d)imidazol-2-yl)-4-chlorophenyl)-5-bromofuran-2-carboxamide
-
Phthalimides
-
Pyridines
-
Receptor, Metabotropic Glutamate 5
-
Receptors, Metabotropic Glutamate
-
Thiazoles
-
6-methyl-2-(phenylethynyl)pyridine